Primary testicular diffuse large B-cell lymphoma belongs to the nongerminal center B-cell-like subgroup: a study of 18 cases

被引:77
作者
Al-Abbadi, Mousa A.
Hattab, Eyas M.
Tarawneh, Musleh S.
Amr, Samir S.
Orazi, Attilio
Ulbright, Thomas M.
机构
[1] Wayne State Univ, Dept Pathol, Detroit, MI 48202 USA
[2] Indiana Univ, Sch Med, Dept Pathol, Indianapolis, IN 46204 USA
[3] Univ Jordan, Dept Pathol, Amman, Jordan
[4] Dhahran Med Ctr, Saudi Aramco Med Serv, Dept Pathol, Dhahran, Saudi Arabia
关键词
primary testicular lymphoma; diffuse large cell lymphoma; subclassification; immunophenotype; B-cell lymphoma;
D O I
10.1038/modpathol.3800691
中图分类号
R36 [病理学];
学科分类号
100104 [病理学与病理生理学];
摘要
The most common type of primary testicular lymphoma is diffuse large B-cell type, which has the potential for aggressive clinical behavior. Diffuse large B-cell lymphoma can be further subclassified into two major prognostic categories: germinal center B-cell-like and nongerminal center B-cell-like. Such distinction is made possible using the immunohistochemical expression of CD10, Bcl-6 and MUM1. The aim of this study was to stratify primary testicular lymphoma of the diffuse large B-cell type according to this scheme. Immunohistochemical stains for CD10, Bcl-6 and MUM1 were performed on 18 cases of primary testicular lymphoma of diffuse large B-cell type. Subclassification was carried out as previously described where CD10 and/or Bcl-6 positivity and negativity for MUM1 were considered indicative of germinal center B-cell-like type and the opposite expression as nongerminal center B-cell-like type. The proliferative activity was determined using immunostaining with the Ki-67 antibody. Of 18 cases, 16 (89%) were found to belong to the nongerminal center B-cell-like type. Two cases (11%) were classified as germinal center B-cell-like type; one had a CD10-positive, Bcl-6-positive and MUM1-negative profile, and the other was CD10 negative, Bcl-6 positive and MUM1 negative. The former occurred in a 38-year-old patient who was human immunodeficiency virus positive. All the cases expressed high proliferative activity (>= 50% Ki-67 labeling). We conclude that most (89%) primary testicular lymphomas of the diffuse large B-cell type belong to the nongerminal center B-cell-like subgroup and have high proliferative activity.
引用
收藏
页码:1521 / 1527
页数:7
相关论文
共 53 条
[1]
Ahmad Manzoor, 1994, JPMA (Journal of the Pakistan Medical Association), V44, P86
[2]
Akasaka T, 2000, BLOOD, V96, P2907
[3]
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].
Alizadeh, AA ;
Eisen, MB ;
Davis, RE ;
Ma, C ;
Lossos, IS ;
Rosenwald, A ;
Boldrick, JG ;
Sabet, H ;
Tran, T ;
Yu, X ;
Powell, JI ;
Yang, LM ;
Marti, GE ;
Moore, T ;
Hudson, J ;
Lu, LS ;
Lewis, DB ;
Tibshirani, R ;
Sherlock, G ;
Chan, WC ;
Greiner, TC ;
Weisenburger, DD ;
Armitage, JO ;
Warnke, R ;
Levy, R ;
Wilson, W ;
Grever, MR ;
Byrd, JC ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
NATURE, 2000, 403 (6769) :503-511
[4]
Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma [J].
Barrans, SL ;
Carter, I ;
Owen, RG ;
Davies, FE ;
Patmore, RD ;
Haynes, AP ;
Morgan, GJ ;
Jack, AS .
BLOOD, 2002, 99 (04) :1136-1143
[5]
BUZELIN F, 1994, EUR UROL, V26, P71
[6]
Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus-related lymphomas [J].
Carbone, A ;
Gloghini, A ;
Larocca, LM ;
Capello, D ;
Pierconti, F ;
Canzonieri, V ;
Tirelli, U ;
Dalla-Favera, R ;
Gaidano, G .
BLOOD, 2001, 97 (03) :744-751
[7]
BCL-6 PROTEIN IS EXPRESSED IN GERMINAL-CENTER B-CELLS [J].
CATTORETTI, G ;
CHANG, CC ;
CECHOVA, K ;
ZHANG, JD ;
YE, BH ;
FALINI, B ;
LOUIE, DC ;
OFFIT, K ;
CHAGANTI, RSK ;
DALLAFAVERA, R .
BLOOD, 1995, 86 (01) :45-53
[8]
BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor [J].
Chang, CC ;
Ye, BH ;
Chaganti, RSK ;
DallaFavera, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (14) :6947-6952
[9]
Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma [J].
Colomo, L ;
Löpez-Guillermo, A ;
Perales, M ;
Rives, S ;
Martínez, A ;
Bosch, F ;
Colomer, D ;
Falini, B ;
Montserrat, E ;
Campo, E .
BLOOD, 2003, 101 (01) :78-84
[10]
NON-HODGKINS-LYMPHOMA OF THE TESTIS [J].
CRELLIN, AM ;
HUDSON, BV ;
BENNETT, MH ;
HARLAND, S ;
HUDSON, GV .
RADIOTHERAPY AND ONCOLOGY, 1993, 27 (02) :99-106